Abstracts tagged "population studies and rheumatoid arthritis (RA)"

Abstract Number: 229 • 2018 ACR/ARHP Annual Meeting
Disability Status, Mortality, and Leading Causes of Death in Seropositive Rheumatoid Arthritis Patients: A Population-Based Study in Korea
In Ah Choi¹, Jeong Seok Lee^2,3 and Eun Young Lee², ¹Division of Rheumatology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea, Republic of (South), ²Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South), ³Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea, Republic of (South)
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to functional disability and premature mortality. We aimed to identify the status of disability…
Abstract Number: 230 • 2018 ACR/ARHP Annual Meeting
Increased Prevalence of Coronary Artery Disease in Patients with Chest Pain and Seropositive Rheumatoid Arthritis: An Analysis from a Clinical Computed Tomography-Based Large-Scale Population Cohort
Andreas Bugge Tingaard¹, Annette de Thurah², Ina Trolle Andersen³, Anders Hammerich Riis³, Josephine Therkildsen⁴, Ellen-Margrethe Hauge⁵ and Morten Böttcher⁴, ¹Department of Cardiology, Regional Hospital of Herning, Herning, Denmark, ²Department of Rheumatology,, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark, ³Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, ⁴Cardiology, Regional Hospital of Herning, Herning, Denmark, ⁵Department of Rheumatology, Aarhus University Hospital, Aarhus, Aarhus, Denmark
Background/Purpose: Inflammation seems to play a central role in the development of atherosclerosis and inflammatory diseases seem to promote progression of coronary artery disease (CAD).…
Abstract Number: 840 • 2017 ACR/ARHP Annual Meeting
Mortality Post Hip Fracture in Rheumatoid Arthritis Compared to General Population Controls, a Population-Based Study
C. Allyson Jones¹, Pierre Guy², Hui Xie³, Eric C. Sayre⁴ and Diane Lacaille^5,6, ¹Physical Therapy, University of Alberta, Edmonton, AB, Canada, ²Department of Orthopaedics, University of British Columbia / Centre for Hip Health and Mobility, Vancouver, BC, Canada, ³Biostatistics, Faculty of Health Sciences, Simon Fraser University / Arthritis Research Canada, Burnaby, BC, Canada, ⁴Arthritis Research Canada, Richmond, BC, Canada, ⁵University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada, ⁶Arthritis Research Canada/ University of British Columbia, Vancouver, BC, Canada
Background/Purpose: In prior work, we found a higher incidence of hip fractures in RA than age and sex matched general population controls (4.1 vs. 2.9…
Abstract Number: 1969 • 2017 ACR/ARHP Annual Meeting
Prevalence and Predictive Value over 16 Years of Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies in the General Population
Elena Generali¹, Natasa Isailovic¹, Maria De Santis¹, Angela Ceribelli¹, Fausto Alborghetti², Guido Colloredo³, Luisa Porrati², Torsten Matthias⁴, Alberto Zucchi², Giacomo Maria Guidelli¹, Marta Caprioli¹ and Carlo Selmi^1,5, ¹Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (MI), Italy, ²Bergamo Local Health Authority (ASL), Bergamo, Italy, ³Division of Internal Medicine, San Pietro Hospital, Ponte San Pietro (BG), Italy, ⁴Aesku.Diagnostics, Wendelsheim, Germany, ⁵BIOMETRA Department, University of Milan, Milan, Italy
Background/Purpose: The prevalence of Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies in the general population may vary widely, as RF is present in…
Abstract Number: 2398 • 2017 ACR/ARHP Annual Meeting
A Population-Based Cohort Study of Chronic Obstructive Pulmonary Disease Among Patients with Rheumatoid Arthritis: Comorbidity and Mortality
Charlotte Hyldgaard¹, Elisabeth Bendstrup¹, Alma Becic Pedersen², Sinna Pilgaard Ulrichsen³, Anders Løkke¹, Ole Hilberg⁴ and Torkell Ellingsen^5,6, ¹Pulmonology, Århus University Hospital, Århus, Denmark, ²Clinical Epidemiology, Århus University Hospital, Århus, Denmark, ³Clinicla Epidemiology, Århus University Hospital, Århus, Denmark, ⁴Internal medicine, Vejle Hospital, Vejle, Denmark, ⁵Diagnostic Centre, Region Hospital Silkeborg, Silkeborg, Denmark, ⁶Department of Rheumatology, Odense University Hospital, Odense, DK, Odense, Denmark
Background/Purpose: Only few studies have addressed the prognostic impact of chronic obstructive pulmonary disease (COPD) among patients with rheumatoid arthritis (RA), although both diseases are…
Abstract Number: 142 • 2017 ACR/ARHP Annual Meeting
Incidence of Hip Fracture in Rheumatoid Arthritis: British Columbia, Canada
C. Allyson Jones¹, Pierre Guy², Hui Xie³, Eric C. Sayre⁴ and Diane Lacaille^5,6, ¹Physical Therapy, University of Alberta, Edmonton, AB, Canada, ²Department of Orthopaedics, University of British Columbia / Centre for Hip Health and Mobility, Vancouver, BC, Canada, ³Biostatistics, Faculty of Health Sciences, Simon Fraser University / Arthritis Research Canada, Burnaby, BC, Canada, ⁴Arthritis Research Canada, Richmond, BC, Canada, ⁵Arthritis Research Canada/ University of British Columbia, Vancouver, BC, Canada, ⁶University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada
Background/Purpose: Hip fractures have serious long-term effects, including a high 1-year mortality rate (usually 20-30%) and poor functional recovery, with approximately 50% not attaining pre-fracture…
Abstract Number: 217 • 2017 ACR/ARHP Annual Meeting
Keeping a Balance: Social Engagement and Care Giving
Elizabeth M. Badley^1,2, Dov Millstone² and Anthony V. Perruccio^2,3,4, ¹Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, ²Health Care & Outcomes Research, Krembil Research Institute, University Health Network, Toronto, ON, Canada, ³Arthritis Program, Krembil Research Institute, University Health Network, Toronto, ON, Canada, ⁴Institute of Health Policy, Management & Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
Background/Purpose: Arthritis is associated with pain and disability. As a result there has been some interest in examining the receipt of care among those with…
Abstract Number: 526 • 2016 ACR/ARHP Annual Meeting
Changes in the Functional Status of the Rheumatoid Arthritis (RA) Population over the Biologic Era
Brenna Brady¹, Nicole Gerlanc¹, David Collier² and Bradley S. Stolshek³, ¹Health Analytics, LLC, Columbia, MD, ²Amgen Inc., Thousand Oaks, CA, ³Amgen, Thousand Oaks, CA
Background/Purpose: In 1998, the first biologic disease modifying antirheumatic drug was approved in the United States for the treatment of RA. Since that time, biologics…
Abstract Number: 2235 • 2016 ACR/ARHP Annual Meeting
Utilization of Ambulatory Physician Encounters, Emergency Room Visits and Hospitalizations By RA Patients: A 13 Year Population Health Study
John G Hanly¹, Kara Thompson² and Chris Skedgel³, ¹Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, ²Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, ³Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, United Kingdom
Background/Purpose: To determine total and subspecialty physician encounters, emergency room (ER) visits and hospitalizations in an incident cohort of rheumatoid arthritis (RA) cases and matched…
Abstract Number: 2103 • 2015 ACR/ARHP Annual Meeting
Temporal Trends in Drug Prescription, Utilization and Costs Among Rheumatoid Arthritis (RA) Patients Show Wide Regional Variation Despite Universal Drug Coverage
Mark Tatangelo¹, Michael Paterson², George A. Tomlinson³, Nick Bansback⁴, Jessica Widdifield⁵, Tara Gomes² and Claire Bombardier⁶, ¹University of Toronto, Toronto, ON, Canada, ²Institute of Clinical Evaluative Sciences, Toronto, ON, Canada, ³Medicine, Mount Sinai Hospital, Toronto, ON, Canada, ⁴Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, ⁵University Health Network, Toronto, ON, Canada, ⁶18 Strathearn Blvd, University of Toronto, Toronto, ON, Canada
Background/Purpose: Monitoring of drug use and costs can: describe trends in expenditures over time, identify regional variations in access and indicate physicians' uptake of best-practice…
Abstract Number: 3240 • 2015 ACR/ARHP Annual Meeting
Improved Survival in Rheumatoid Arthritis: A General Population-Based Study
Na Lu^1,2, Hyon K. Choi³, Sara R. Schoenfeld³, Christine Peloquin⁴, Maureen Dubreuil⁵, Sharan K. Rai⁶, J Antonio Avina-Zubieta⁷ and Yuqing Zhang⁸, ¹Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Boston University School of Medicine, Boston, MA, ³Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁴Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁵Rheumatology, Boston VA HealthCare System, Boston, MA, ⁶Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, ⁷Arthritis Research Canada / University of British Columbia, Vancouver, BC, Canada, ⁸BUSM, Boston, MA
Background/Purpose: All-cause mortality in UK has been decline by almost 20% over the past two decades. While rheumatoid arthritis (RA) is associated with an increased…
Abstract Number: 1020 • 2013 ACR/ARHP Annual Meeting
The Impact Of Diagnostic Decision Rules Used In Administrative Healthcare Databases On The Frequency Of Rheumatoid Arthritis and Systemic Lupus Erythematosus
John G. Hanly¹, Kara Thompson² and Chris Skedgel¹, ¹Division of Rheumatology, Dalhousie University and Capital Health, Halifax, NS, Canada, ²Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada
Background/Purpose: To compare the incidence and prevalence of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) in administrative databases using different diagnostic decision rules. Methods:…
Abstract Number: 1198 • 2012 ACR/ARHP Annual Meeting
Cardiovascular Risk Factors and Events Are More Frequent Prior to the Onset of Rheumatoid Arthritis Than in the General Population
Helen Pahau Sr.¹, Vibeke Videm², Sanjoy Paul³ and Ranjeny Thomas⁴, ¹Diamantina Institute, University of Queensland Diamantina Institute, Brisbane, Australia, ²Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, and Department of Immunology and Transfusion Medicine, Trondheim University Hospital,, Trondheim, Norway, ³University of Queensland School of Population Health, Brisbane, Australia, ⁴University of Queensland Diamantina Institute, Brisbane, Australia
Background/Purpose: Patients with the inflammatory autoimmune disease Rheumatoid Arthritis (RA) have a higher mortality and morbidity than the general population, predominantly related to cardiovascular disease…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].